68630 Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 

access services to ensure AA and NHPI 

communities can access Federal 

programs and services; and strategies to 

increase public-and private-sector 

collaboration, and community 

involvement in improving the safety 

and socioeconomic, health, educational, 

occupational, and environmental wellbeing of AA and NHPI communities. 

Information is available on the 

President’s Advisory Commission on 

Asian Americans, Native Hawaiians, 

and Pacific Islanders website at https:// 

www.hhs.gov/about/whiaanhpi/ 

commission/index.html. The names of 

the 25 members of the President’s 

Advisory Commission on Asian 

Americans, Native Hawaiians, and 

Pacific Islanders are available at https:// 

www.hhs.gov/about/whiaanhpi/ 

commission/commissioners/index.html. 

Purpose of Meeting: The President’s 

Advisory Commission on Asian 

Americans, Native Hawaiians, and 

Pacific Islanders, authorized by 

Executive Order 14031, will meet to 

discuss full and draft recommendations 

by the Commission’s six Subcommittees 

on ways to advance equity, justice, and 

opportunity for Asian American, Native 

Hawaiian, and Pacific Islander 

communities. The Subcommittees are: 

Belonging, Inclusion, Anti-Asian Hate, 

Anti-Discrimination; Data 

Disaggregation; Language Access; 

Economic Equity; Health Equity; and 

Immigration and Citizenship Status. 

Background: Asian American, Native 

Hawaiian, and Pacific Islander 

communities are among the fastest 

growing racial and ethnic populations 

in the United States according to the 

U.S. Census Bureau. However, in recent 

years, AA and NHPI individuals have 

faced increasing hate crimes and 

incidents that threaten their safety, as 

well as harmful stereotypes that often 

ignore socioeconomic, health, and 

educational disparities impacting these 

diverse communities. 

During the COVID–19 pandemic, 

tragic acts of anti-Asian violence 

increased and cast a shadow of fear and 

grief over many AA and NHPI 

communities. However, even before the 

pandemic, AA and NHPI communities 

in the United States have faced 

persistent xenophobia, religious 

discrimination, racism, and violence. 

At the same time, AA and NHPI 

communities were overrepresented in 

the pandemic’s essential workforce in 

healthcare, food supply, education, and 

childcare, with more than four million 

AA and NHPIs manning the frontlines. 

Many AA and NHPI workers, families, 

and small businesses also faced 

devastating economic losses during this 

time. 

Additionally, health and economic 

inequities faced by Native Hawaiian and 

Pacific Islander communities worsened 

during the COVID–19 pandemic, with 

evidence suggesting they were twice as 

likely to die from the disease compared 

to white counterparts. 

The challenges AA and NHPI 

communities face are often exacerbated 

by a lack of adequate data 

disaggregation and language access. The 

President’s Advisory Commission on 

Asian Americans, Native Hawaiians, 

and Pacific Islanders works to advise 

the President on executive branch 

efforts to address these challenges and 

advance equity, justice, and opportunity 

for AA and NHPI communities. 

Public Participation at Meeting: 

Members of the public may attend 

virtually. Registration is required 

through the following link: https:// 

www.eventbrite.com/e/meeting-of-thepresidents-advisory-commission-on-aaand-nhpis-tickets-715434733547?aff=

oddtdtcreator. 

Written public comments: Written 

comments are welcomed throughout the 

development of the Commission’s 

recommendations to promote equity, 

justice, and opportunity for Asian 

Americans, Native Hawaiians, and 

Pacific Islanders and may be emailed to 

AANHPICommission@hhs.gov at any 

time. Respond concisely and in plain 

language. You may use any structure or 

layout that presents your information 

well. You may include links to online 

material or interactive presentations. 

Clearly mark any proprietary 

information and place it in its own 

section or file. Your response will 

become Government property, and we 

may publish some of its non-proprietary 

content. 

Authority: Executive Order 14031. 

The President’s Advisory Commission 

on Asian Americans, Native Hawaiians, 

and Pacific Islanders (Commission) is 

governed by provisions of the Federal 

Advisory Committee Act (FACA), Public 

Law 92–463, as amended (5 U.S.C. 

App.), which sets forth standards for the 

formation and use of Federal advisory 

committees. 

Krystal Ka’ai, 

Executive Director, White House Initiative on 

Asian Americans, Native Hawaiians, and 

Pacific Islanders, President’s Advisory 

Commission on Asian Americans, Native 

Hawaiians, and Pacific Islanders. 

[FR Doc. 2023–21981 Filed 10–3–23; 8:45 am] 

BILLING CODE 4150–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Special Diabetes Program for Indians 

Announcement Type: New. 

Funding Announcement Number: 

HHS–2024–IHS–SDPI–0001. 

Assistance Listing (Catalog of Federal 

Domestic Assistance or CFDA) Number: 

93.237. 

Key Dates 

Application Deadline Date: November 

29, 2023. 

Earliest Anticipated Start Date: 

January 1, 2024. 

I. Funding Opportunity Description 

Statutory Authority 

The Indian Health Service (IHS) is 

accepting applications for the Special 

Diabetes Program for Indians (SDPI— 

formerly Community-Directed SDPI). 

This program is authorized under the 

Snyder Act, 25 U.S.C. 13; the Transfer 

Act, 42 U.S.C. 2001(a); and Section 

330C of the Public Health Service Act, 

codified at 42 U.S.C. 254c–3. The 

Assistance Listings section of SAM.gov 

(https://sam.gov/content/home) 

describes this program under 93.237. 

Background 

Diabetes is a complex and costly 

chronic disease that requires 

tremendous long-term efforts to prevent 

and treat. Although diabetes is a 

nationwide public health problem, 

American Indian/Alaska Native (AI/AN) 

people are disproportionately affected. 

In 2019, 14.5 percent of AI/AN people 

aged 18 years or older had diagnosed 

diabetes, compared to 7.4 percent of 

non-Hispanic white people [CDC, 2021. 

https://www.cdc.gov/diabetes/data/ 

statistics-report/diagnoseddiabetes.html]. In addition, AI/AN 

people have higher rates of diabetesrelated morbidity and mortality than the 

general U.S. population [O’Connell, 

2010 (https://diabetesjournals.org/care/ 

article/33/7/1463/39326/RacialDisparities-in-Health-StatusAcomparison-of); Cho, 2014 (http://

ajph.aphapublications.org/doi/full/ 

10.2105/AJPH.2014.301968)]. Strategies 

to address the prevention and treatment 

of diabetes in AI/AN communities are 

urgently needed. 

In response to the burgeoning diabetes 

epidemic among AI/AN people, 

Congress established the SDPI through 

the Balanced Budget Act of 1997. SDPI 

is a $150 million per year program that 

provides awards for diabetes treatment 

and prevention services. The IHS 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 68631 

administers SDPI, with programmatic 

oversight provided by the IHS Division 

of Diabetes Treatment and Prevention 

(DDTP). 

Purpose 

The purpose of this program is to 

provide diabetes treatment and/or 

prevention activities and/or services 

(also referred to as ‘‘activities/services’’) 

for AI/AN communities. Recipients will 

implement one SDPI Diabetes Best 

Practice (also referred to as ‘‘Best 

Practice’’) and report data on the Best 

Practice’s Required Key Measure (RKM). 

Recipients may also implement other 

activities/services based on diabetesrelated community needs and develop 

an evaluation plan. Activities/services 

will be aimed at reducing the risk of 

diabetes in at-risk individuals, 

providing high quality care to those 

with diagnosed diabetes, and/or 

reducing the complications of diabetes. 

II. Award Information 

Funding Instrument—Cooperative 

Agreement 

Estimated Funds Available 

The total funding identified for this 

announcement’s period of performance 

is approximately $40 million, with the 

IHS awarding approximately $10 

million each budget year, starting with 

fiscal year (FY) 2024. Individual award 

amounts for the first budget year are 

anticipated to be between $25,000 and 

$600,000. 

The funding formula, which 

determines the funds available to each 

IHS area, has been determined through 

Tribal consultation. Within each area, 

recipient Tribes provide input on the 

formula, which determines the amount 

of funding available for each successful 

applicant. 

• Previously awarded SDPI recipients 

applying to this announcement should 

budget for the same amount as they 

received in previous years. However, 

funding amounts may change. See the 

paragraph below for additional 

information. 

• New SDPI award applicants should 

apply for a $25,000 base amount. 

However, funding amounts may change 

based on each specific Area’s funding 

formula. See the paragraph above. 

The funding available for competing 

and subsequent continuation awards 

issued under this announcement is 

subject to the availability of 

appropriations and budgetary priorities 

of the Agency. The IHS is under no 

obligation to make awards to applicants 

selected for funding under this 

announcement. 

Anticipated Number of Awards 

Approximately 7–20 awards will be 

issued under this program 

announcement. 

Period of Performance 

The period of performance is for 4 

years. 

Cooperative Agreement 

Cooperative agreements awarded by 

the Department of Health and Human 

Services (HHS) are administered under 

the same policies as grants. However, 

the funding agency, IHS, is anticipated 

to have substantial programmatic 

involvement in the project during the 

entire period of performance. Below is 

a detailed description of the level of 

involvement required of the IHS. 

Substantial Agency Involvement 

Description for Cooperative Agreement 

A. DDTP will provide programmatic 

oversight, including: 

1. Award Requirements 

a. Create and maintain Best Practices: 

focused areas for improvement of 

diabetes prevention and treatment 

outcomes in communities and clinics. 

b. Annual Progress Report: Create and 

provide instructions and template(s). 

2. Data Collection and Analysis 

a. IHS Diabetes Care and Outcomes 

Audit: Provide resources, tools, support, 

and training. 

b. SDPI Outcomes System (SOS): 

Create and provide resources, tools, 

support, and training. Recipients will 

use the SOS to track and report on RKM 

data for their selected Best Practice. 

3. Training, Communication, and 

Technical Assistance 

a. Provide extensive SDPI awardrelated trainings: Topics include 

Application, Annual Progress Report, 

and others. Most trainings are provided 

via live webinars. Webinars will be 

recorded and made available on the 

SDPI website based on importance. 

b. Provide updates and 

announcements via email. 

c. Maintain and update the IHS SDPI 

website (https://www.ihs.gov/sdpi/), 

which provides information and 

resources regarding this cooperative 

agreement, including: 

i. Best Practices. 

ii. Additional resources—Documents 

and links from DDTP and the Division 

of Grants Management (DGM). 

iii. New to SDPI—Information for new 

recipients and/or staff. 

4. Diabetes Trainings and Resources 

a. Provide diabetes-related live, 

recorded, and online education 

developed by the DDTP, designed for 

clinicians and other health professionals 

serving in the Indian health system. 

b. Provide clinical updates and 

announcements via email. 

c. Maintain and update the DDTP 

website, which provides additional 

resources for recipients including: 

i. Clinician resources—online 

continuing education opportunities, 

diabetes treatment algorithms, IHS 

Standards of Care and Clinical Practice 

Recommendations for Type 2 Diabetes, 

and IHS Diabetes Care and Outcomes 

Audit resources. 

ii. Patient education resources—free 

materials that can be ordered, printed, 

or downloaded from the online catalog. 

B. The Indian Health Care 

Improvement Act, amended in 1987, 

established that each of the 12 IHS 

Areas should have an Area Diabetes 

Consultant (ADC). The ADCs are health 

care professionals with expertise in 

diabetes. They play a critical role in 

supporting SDPI diabetes treatment and 

prevention activities for their Area 

including: 

1. Oversee SDPI awards within their 

specified Area to ensure compliance 

with programmatic Terms and 

Conditions. 

2. Serve as a liaison between the SDPI 

award programs, DDTP, and DGM. 

3. Provide training and resources to 

SDPI recipients. Some resources may be 

in the form of additional staff serving as 

ADC support. 

4. Review or assign a designee to 

review annual continuation 

applications. 

5. May serve as the Program Officer 

for the SDPI award programs in their 

IHS Area. The Program Officer is a 

Federal staff person who is responsible 

for managing and monitoring the 

progress of recipients in GrantSolutions. 

If the ADC is not eligible (i.e., not 

Federal program staff), another 

individual may serve as the Program 

Officer in a limited capacity. Program 

Officer’s duties include: creating 

funding commitments and memos, 

providing programmatic review/ 

approval of amendments, and assisting 

in uploading documents and 

information as Grant Notes in 

GrantSolutions. 

Required, Optional, and Allowable 

Activities 

Required 

All recipients will need to meet the 

following requirements: 

1. Activities/Services: Recipients must 

provide activities/services that: 

a. meet the purpose of the SDPI, 

which is to provide diabetes treatment 


lotter on DSK11XQN23PROD with NOTICES1
68632 Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 

and/or prevention services and 

activities for AI/AN communities; 

b. are targeted at reducing risk factors 

for diabetes and diabetes-related 

conditions; 

c. address diabetes-related issues as 

identified in the recipient’s application; 

and 

d. use SDPI funds as outlined in the 

recipient’s Budget Narrative. 

2. IHS Diabetes Care and Outcomes 

Audit (Diabetes Audit): SDPI recipients 

are required to participate in the Annual 

Diabetes Audit (https://www.ihs.gov/ 

diabetes/audit/). Recipients will submit 

data, review results, and provide a copy 

of their Annual Diabetes Audit Report 

with their Continuation Applications. 

Non-clinical or community-based 

awardees that are not able to directly 

participate in the Diabetes Audit, will 

need to obtain a copy of the Annual 

Diabetes Audit Report from their local 

facility or Area Diabetes Consultant 

(https://www.ihs.gov/diabetes/about-us/ 

area-diabetes-consultants-adc/). 

3. Best Practices: The Best Practices 

(https://www.ihs.gov/sdpi/sdpicommunity-directed/diabetes-bestpractices/) include the latest scientific 

findings and recommendations. 

Recipients must select one Best Practice 

and implement activities/services aimed 

at improving the associated RKM. 

Recipients will report on RKM data via 

the SOS. 

4. Collaboration: Recipients must: 

a. Consult with and accept guidance 

from DDTP, DGM, and their ADC/ADC 

Support/Federal Program Officer(s) and/ 

or designated assignee(s). 

b. Respond promptly to requests for 

information. 

c. Attend required meetings and 

trainings. 

d. Provide short presentations on their 

processes and successes, as requested. 

e. Keep the entities (see item a. above) 

informed of emerging issues, 

developments, and challenges that may 

affect the recipient’s ability to comply 

with the award Terms and Conditions 

and/or any requirements. 

5. Project Director: Recipients must 

have an officially approved Project 

Director (approved by the Grants 

Management Officer in consultation 

with the Program Official) who has the 

following qualifications: 

a. Relevant health or wellness 

education and/or experience. 

b. Experience with award program 

management, including skills in 

program coordination, budgeting, 

reporting, and staff supervision. 

c. Working knowledge of diabetes. 

The Project Director should routinely 

update relevant SDPI award program 

staff with information and requirements 

regarding their program’s activities/ 

services. 

6. Annual Progress Report: Per DGM 

policy, the recipient must complete an 

annual progress report and submit it 

within 90 days of the end of the budget 

period. The recipient will submit the 

report by uploading it into a Grant Note 

in GrantSolutions. DDTP will post 

instructions, template(s), and other 

information on the SDPI Application/ 

Report website (https://www.ihs.gov/ 

sdpi/sdpi-community-directed/ 

application-reports/). 

7. Required Trainings: Recipients 

must participate in SDPI required 

trainings provided by DDTP. These will 

primarily be live webinars, which will 

be recorded and posted on the SDPI 

website for those not able to attend. 

Recipients will be expected to keep 

track of participation (both live and 

recorded webinars). Information about 

the SDPI awardee training requirements 

will be provided on the SDPI Grant 

Training website (https://www.ihs.gov/ 

sdpi/sdpi-community-directed/sdpigrant-training/). 

Optional 

1. Optional Trainings: In addition to 

required training, DDTP also provides 

optional trainings. Recipients may 

participate in SDPI optional trainings 

depending on their need for the 

information that will be presented. 

These will primarily be live webinars, 

which will be recorded and posted on 

the SDPI website for those not able to 

attend. Recipients are not expected to 

keep track of participation, but a 

training tracking tool is made available 

and updated regularly, providing all 

required and optional trainings hosted 

by DDTP for the year. Information about 

the SDPI recipient training requirements 

will be provided on the SDPI Grant 

Training website (https://www.ihs.gov/ 

sdpi/sdpi-community-directed/sdpigrant-training/). 

2. Diabetes in Indian Country 

Conference: DDTP occasionally hosts a 

conference that provides continuing 

education opportunities and 

collaboration on issues related to 

improving outcomes for people with 

diabetes and those at risk for developing 

diabetes. SDPI award training sessions 

are provided during this conference. 

SDPI recipient attendance is encouraged 

but not required. 

Allowable 

1. Allowable Activities/Services: 

There are many types of activities/ 

services allowed under this award as 

long as they meet the activities/services 

requirement (see Required.1. above) and 

are within the scope of work defined in 

the Project Narrative. For questions, 

contact DDTP. 

III. Eligibility Information 

1. Eligibility 

To be eligible for this FY 2024 

funding opportunity, applicants must be 

one of the following as required by 42 

U.S.C. 254c–3(b): 

• An Indian health program operated 

by an Indian Tribe or Tribal 

organization pursuant to a contract, 

grant, cooperative agreement, or 

compact with the Indian Health Service 

pursuant to the Indian SelfDetermination and Education 

Assistance Act [25 U.S.C. 5321 et seq.]. 

• An urban Indian health program 

operated by an urban Indian 

Organization pursuant to a grant or 

contract with the Indian Health Service 

pursuant to title V of the Indian Health 

Care Improvement Act [25 U.S.C. 1651 

et seq.]. 

• The Indian Health Service. Under 

this announcement, only one SDPI grant 

will be awarded per entity. If a Tribe 

submits an application or already has an 

SDPI grant, their local IHS facility 

cannot apply; if the Tribe does not 

submit an application or does not 

already have an SDPI grant, the IHS 

facility can apply. Tribes that are 

awarded grant funds may sub-contract 

with local IHS facilities to provide 

specific clinical services. In this case, 

the Tribe would be the primary SDPI 

grantee and the Federal entity would 

have a sub-contract within the Tribe’s 

SDPI grant. 

• Not a current SDPI grant recipient. 

The Division of Grants Management 

(DGM) will notify any applicants 

deemed ineligible. 

2. Additional Information on Eligibility 

The IHS does not fund concurrent 

projects. If an applicant is successful 

under this announcement, any 

subsequent applications in response to 

other SDPI announcements from the 

same applicant will not be funded. 

Applications on behalf of individuals 

(including sole proprietorships) and 

foreign organizations are not eligible. 

Applications deemed ineligible will be 

disqualified from competitive review 

and funding under this funding 

opportunity. 

Note: Please refer to Section IV.2 

(Application and Submission Information/ 

Subsection 2, Content and Form of 

Application Submission) for additional proof 

of applicant status documents required, such 

as Tribal Resolutions, proof of nonprofit 

status, etc. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 68633 

3. Cost Sharing or Matching 

The IHS does not require matching 

funds or cost sharing for grants or 

cooperative agreements. 

4. Other Requirements 

Applications with budget requests 

that exceed the highest dollar amount 

outlined under Section II Award 

Information, Estimated Funds Available, 

or exceed the period of performance 

outlined under Section II Award 

Information, Period of Performance, are 

considered not responsive and will not 

be reviewed. The DGM will notify the 

applicant. 

Additional Required Documentation 

Tribes and Tribal Organizations 

Tribal Resolution 

The DGM must receive an official, 

signed Tribal Resolution prior to issuing 

a Notice of Award (NoA) to any Tribe 

or Tribal organization selected for 

funding. An applicant that is proposing 

a project affecting another Indian Tribe 

must include resolutions from all 

affected Tribes to be served. However, if 

an official signed Tribal Resolution 

cannot be submitted with the 

application prior to the application 

deadline date, a draft Tribal Resolution 

must be submitted with the application 

by the deadline date in order for the 

application to be considered complete 

and eligible for review. The draft Tribal 

Resolution is not in lieu of the required 

signed resolution, but is acceptable until 

a signed resolution is received. If an 

application without a signed Tribal 

Resolution is selected for funding, the 

applicant will be contacted by the 

Grants Management Specialist (GMS) 

listed in this funding announcement 

and given 90 days to submit an official, 

signed Tribal Resolution to the GMS. If 

the signed Tribal Resolution is not 

received within 90 days, the award will 

be forfeited. 

Applicants organized with a 

governing structure other than a Tribal 

council may submit an equivalent 

document commensurate with their 

governing organization. 

Proof of Nonprofit Status 

Organizations claiming nonprofit 

status must submit a current copy of the 

501(c)(3) Certificate with the 

application. 

IV. Application and Submission 

Information 

Grants.gov uses a Workspace model 

for accepting applications. The 

Workspace consists of several online 

forms and three forms in which to 

upload documents—Project Narrative, 

Budget Narrative, and Other Documents. 

Give your files brief descriptive names. 

The filenames are key in finding 

specific documents during the objective 

review and in processing awards. 

Upload all requested and optional 

documents individually, rather than 

combining them into a package. 

Creating a package creates confusion 

when trying to find specific documents. 

Such confusion can contribute to delays 

in processing awards, and could lead to 

lower scores during the objective 

review. 

1. Obtaining Application Materials 

The application package and detailed 

instructions for this announcement are 

available at https://www.Grants.gov. 

Please direct questions regarding the 

application process to DGM@ihs.gov. 

2. Content and Form Application 

Submission 

Mandatory documents for all 

applications are listed below. An 

application is incomplete if any of the 

listed mandatory documents are 

missing. Incomplete applications will 

not be reviewed. 

• Application forms: 

1. SF–424, Application for Federal 

Assistance. 

2. SF–424A, Budget Information— 

Non-Construction Programs. 

3. SF–424B, Assurances—NonConstruction Programs. 

4. Project Abstract Summary Form. 

• Project Narrative (not to exceed 18 

pages). See Section IV.2.A, Project 

Narrative for more information. 

• Budget Justification and Narrative 

(not to exceed seven pages). See Section 

IV.2.B, Budget Narrative for 

instructions. 

• One-page Timeframe Chart. 

• 2022 and 2023 Annual Diabetes 

Audit reports (DRAFT report for 2023 is 

acceptable) or copies of Audit waivers 

provided by DDTP. 

• Letter(s) of Support from one or 

more of the following: 

1. Board of Directors (Urban Indian 

health programs). 

2. Chief Executive Officer (IHS 

facilities). 

3. Tribes served (highly recommended 

for IHS facilities). 

• Biographical sketches for all Key 

Personnel. 

• Key contacts form for diabetes 

program coordinator. 

• Certification Regarding Lobbying 

(GG-Lobbying Form). 

The documents listed here may be 

required. Please read this list carefully. 

• Tribal Resolution(s) as described in 

Section III, Eligibility. 

• 501(c)(3) Certificate. 

• Disclosure of Lobbying Activities 

(SF–LLL), if applicant conducts 

reportable lobbying. 

• Copy of current Negotiated Indirect 

Cost (IDC) rate agreement (required in 

order to receive IDC). 

• Contractor/Consultant resumes or 

qualifications and scope of work. 

• Documentation of current Office of 

Management and Budget (OMB) 

Financial Audit (if applicable). 

Acceptable forms of documentation 

include: 

1. Email confirmation from Federal 

Audit Clearinghouse (FAC) that audits 

were submitted; or 

2. Face sheets from audit reports. 

Applicants can find these on the FAC 

website at https://facdissem.census 

.gov/. 

Additional documents can be 

uploaded as Other Attachments in 

Grants.gov. These can include: 

• Work plan, logic model, and/or 

timeline for proposed objectives. 

• Position descriptions for key staff. 

• Resumes of key staff that reflect 

current duties. 

• Organizational chart. 

• Map of area identifying project 

location(s). 

• Additional documents to support 

narrative (for example, data tables, and 

key news articles). 

Public Policy Requirements 

All Federal public policies apply to 

IHS grants and cooperative agreements. 

Pursuant to 45 CFR 80.3(d), an 

individual shall not be deemed 

subjected to discrimination by reason of 

their exclusion from benefits limited by 

Federal law to individuals eligible for 

benefits and services from the IHS. See 

https://www.hhs.gov/grants/grants/ 

grants-policies-regulations/index.html. 

Requirements for Project and Budget 

Narratives and Other Programmatic 

Reports 

A. Project Narrative 

This narrative should be a separate 

document that is no more than 18 pages 

and must: (1) have consecutively 

numbered pages; (2) use black font 12 

points or larger (applicants may use 10- 

point font for tables); (3) be singlespaced; and (4) be formatted to fit 

standard letter paper (81⁄2 x 11 inches). 

DDTP provides an optional PDF 

template on the SDPI Application 

website at https://www.ihs.gov/sdpi/ 

sdpi-community-directed/applicationreports/, which applicants can use to 

provide the required information 

instead of developing their own format. 

Be sure to succinctly answer all 

questions listed under the evaluation 


lotter on DSK11XQN23PROD with NOTICES1
68634 Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 

criteria (refer to Section V.1, Evaluation 

Criteria), and place all responses and 

required information in the correct 

section noted below or they will not be 

considered or scored. If the narrative 

exceeds the overall page limit, the 

reviewers will be directed to ignore any 

content beyond the page limit. The 18- 

page limit for the project narrative does 

not include the work plan, standard 

forms, Tribal Resolutions, budget, 

budget narratives, and/or other items. 

Page limits for each section within the 

project narrative are guidelines, not 

hard limits. 

There are six parts to the Project 

Narrative: 

Part A: Program Identifiers/Experience 

(Limit—2 pages) 

Information to identify your program 

including past experience with diabetes 

treatment and preventions in the AI/AN 

Communities (include years of 

experience), geographic location, food 

resources, and relationship or role with 

local Indian health clinic. 

Part B: Needs Assessment (Limit—3 

pages) 

Section 1: Diabetes Needs 

Assessment—identify key diabetesrelated health issues and diabetes 

prevalence. 

Section 2: Review of Diabetes Audit 

Reports 

Obtain and review of 2022 and 2023 

Annual Diabetes Audit Reports, to 

provide 2–3 items/elements that need to 

be improved and how your program will 

address those items/elements. 

Section 3: Challenges 

Identify and describe challenges your 

program experiences or may face related 

to prevention and/or treatment of 

diabetes. 

Part C: Program Support and Resources 

(Limit—3 pages) 

Section 1: Leadership Support 

Identify at least one organization 

administrator or Tribal leaders (other 

than your Program Coordinator) who 

has agreed to support your SDPI 

program for 2024 and describe how they 

will be actively involved with your 

program. 

Section 2: Key Personnel 

List all key personnel that will be 

involved in your program’s activities/ 

services. This may be your ‘‘Diabetes 

Team.’’ You must also separately 

provide a brief resume or biographical 

sketch for all key personnel listed. 

Section 3: Partnerships and 

Collaborations 

List current active partnerships 

related to your SDPI program and 

describe any new partnerships and 

collaborations that your SDPI program is 

planning to implement. Include 

information about how these partners 

and collaborators will contribute to the 

activities/services you plan to provide. 

Part D: SDPI Diabetes Best Practice 

(Limit—3 pages) 

Section 1: Best Practice Selection 

Applicants must select one Best 

Practice that addresses one of the needs 

that was identified in the needs 

assessment (Part B). There is a list of all 

the Best Practices on the Best Practices 

website: https://www.ihs.gov/sdpi/sdpicommunity-directed/diabetes-bestpractices/. For each Best Practice, there 

is a brief statement on the importance, 

RKM information, and guidance for 

selecting a Target Group, and tools and 

resources. 

Section 2: Best Practice Activities 

Provide a list of activity(ies)/service(s) 

to implement that would improve the 

RKM of the selected Best Practice. Each 

activity/service should include a brief 

description and a timeline for 

implementation. 

Section 3: Target Group Number and 

Description 

Recipients will be required to report 

RKM data for one Target Group for their 

selected Best Practice. A Target Group is 

the largest number of patients/ 

participants that you can realistically 

include in the activities/services you 

provided in the Best Practice activities 

for the budget period. The following 

should be considered in selecting your 

Target Group: 

a. The size and characteristics (e.g., 

ages, health status, settings, locations) of 

the community or patient population 

that you are going to draw your Target 

Group from; 

b. Intensity of the activities/services 

you plan to do; 

c. and SDPI funding and other 

resources available to provide activities/ 

services. 

Part E: Activities/Services not related to 

selected Best Practice (Optional. Limit— 

5 pages) 

Provide information for up to five 

major activities/services, supported by 

SDPI funds, to address needs that were 

identified in the needs assessment (Part 

B). Activities/services reported here 

should be based on the following 

criteria: 

a. Use the most award funding and 

program time. 

b. Address significant needs/ 

challenges. 

Part F: Additional Information (Limit— 

2 pages) 

Provide additional information as 

specified by program office. 

B. Budget Narrative (Limit—7 pages) 

Provide a budget narrative that 

explains the amounts requested for each 

line item of the budget from the SF– 

424A (Budget Information for NonConstruction Programs) for the first year 

of the project. The applicant can submit 

with the budget narrative a more 

detailed spreadsheet than is provided by 

the SF–424A (the spreadsheet will not 

be considered part of the budget 

narrative). The budget narrative should 

specifically describe how each item will 

support the achievement of proposed 

objectives. Be very careful about 

showing how each item in the ‘‘Other’’ 

category is justified. For subsequent 

budget years (see Multi-Year Project 

Requirements in Section V.1, 

Application Review Information, 

Evaluation Criteria), the additional 

pages should highlight the changes from 

the first year or clearly indicate that 

there are no substantive budget changes 

during the period of performance. Do 

NOT use the budget narrative to expand 

the project narrative. 

C. IHS Diabetes Care and Outcomes 

Audit 

The IHS Diabetes Care and Outcomes 

Audit is a process to assess care and 

health outcomes for AI/AN people with 

diagnosed diabetes. IHS, Tribal, and 

Urban Indian health care facilities 

nationwide participate in this process 

each year by auditing medical records 

for their patients with diabetes. 

Applicants who are able to must submit 

copies of their local facility’s 2022 and 

2023 Annual Diabetes Audit reports or 

copies of the Audit waivers provided by 

DDTP. 

Annual Diabetes Audit reports can be 

obtained in the following ways: 

a. Via the WebAudit: https://

www.ihs.gov/diabetes/audit/. 

b. Request from their local facility. 

c. Request from their ADC: https://

www.ihs.gov/diabetes/about-us/areadiabetes-consultants-adc/. 

For programs that received Audit 

waivers, these can be found in 

GrantSolutions (as a Grant Note). 

If the applicant is unable to obtain 

their local facility’s 2022 and 2023 

Annual Diabetes Audit Reports, they 

must provide an explanation in their 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 68635 

Project Narrative (Part B). For any 

questions, contact DDTP. 

3. Submission Dates and Times 

Applications must be submitted 

through Grants.gov by 11:59 p.m. 

Eastern Time on the Application 

Deadline Date. Any application received 

after the application deadline will not 

be accepted for review. Grants.gov will 

notify the applicant via email if the 

application is rejected. 

If technical challenges arise and 

assistance is required with the 

application process, contact Grants.gov 

Customer Support (see contact 

information at https://www.Grants.gov). 

If problems persist, contact Mr. Paul 

Gettys, Deputy Director, DGM, by email 

at DGM@ihs.gov. Please be sure to 

contact Mr. Gettys at least 10 days prior 

to the application deadline. Please do 

not contact the DGM until you have 

received a Grants.gov tracking number. 

In the event you are not able to obtain 

a tracking number, call the DGM as soon 

as possible by email at DGM@ihs.gov. 

The IHS will not acknowledge receipt 

of applications. 

4. Intergovernmental Review 

Executive Order 12372 requiring 

intergovernmental review is not 

applicable to this program. 

5. Funding Restrictions 

• Pre-award costs are allowable up to 

90 days before the start date of the 

award provided the costs are otherwise 

allowable if awarded. Pre-award costs 

are incurred at the risk of the applicant. 

• The available funds are inclusive of 

direct and indirect costs. 

• Only one cooperative agreement 

will be awarded per applicant. 

6. Electronic Submission Requirements 

All applications must be submitted 

via Grants.gov. Please use the https://

www.Grants.gov website to submit an 

application. Find the application by 

selecting the ‘‘Search Grants’’ link on 

the homepage. Follow the instructions 

for submitting an application under the 

Package tab. No other method of 

application submission is acceptable. 

If you cannot submit an application 

through Grants.gov, you must request a 

waiver prior to the application due date. 

You must submit your waiver request by 

email to DGM@ihs.gov. Your waiver 

request must include clear justification 

for the need to deviate from the required 

application submission process. The 

IHS will not accept any applications 

submitted through any means outside of 

Grants.gov without an approved waiver. 

If the DGM approves your waiver 

request, you will receive a confirmation 

of approval email containing 

submission instructions. You must 

include a copy of the written approval 

with the application submitted to the 

DGM. Applications that do not include 

a copy of the waiver approval from the 

DGM will not be reviewed. The Grants 

Management Officer of the DGM will 

notify the applicant via email of this 

decision. Applications submitted under 

waiver must be received by the DGM no 

later than 5:00 p.m. Eastern Time on the 

Application Deadline Date. Late 

applications will not be accepted for 

processing. Applicants that do not 

register for both the System for Award 

Management (SAM) and Grants.gov 

and/or fail to request timely assistance 

with technical issues will not be 

considered for a waiver to submit an 

application via alternative method. 

Please be aware of the following: 

• Please search for the application 

package in https://www.Grants.gov by 

entering the Assistance Listing number 

or the Funding Opportunity Number. 

Both numbers are located in the header 

of this announcement. 

• If you experience technical 

challenges while submitting your 

application, please contact Grants.gov 

Customer Support (see contact 

information at https://www.Grants.gov). 

• Upon contacting Grants.gov, obtain 

a tracking number as proof of contact. 

The tracking number is helpful if there 

are technical issues that cannot be 

resolved and a waiver from the agency 

must be obtained. 

• Applicants are strongly encouraged 

not to wait until the deadline date to 

begin the application process through 

Grants.gov as the registration process for 

SAM and Grants.gov could take up to 20 

working days. 

• Please follow the instructions on 

Grants.gov to include additional 

documentation that may be requested by 

this funding announcement. 

• Applicants must comply with any 

page limits described in this funding 

announcement. 

• After submitting the application, 

you will receive an automatic 

acknowledgment from Grants.gov that 

contains a Grants.gov tracking number. 

The IHS will not notify you that the 

application has been received. 

System for Award Management 

Organizations that are not registered 

with the System for Award Management 

(SAM) must access the SAM online 

registration through the SAM home page 

at https://sam.gov. Organizations based 

in the United States (U.S.) will also 

need to provide an Employer 

Identification Number from the Internal 

Revenue Service that may take an 

additional 2–5 weeks to become active. 

Please see SAM.gov for details on the 

registration process and timeline. 

Registration with the SAM is free of 

charge but can take several weeks to 

process. Applicants may register online 

at https://sam.gov. 

Unique Entity Identifier 

Your SAM.gov registration now 

includes a Unique Entity Identifier 

(UEI), generated by SAM.gov, which 

replaces the DUNS number obtained 

from Dun and Bradstreet. SAM.gov 

registration no longer requires a DUNS 

number. 

Check your organization’s SAM.gov 

registration as soon as you decide to 

apply for this program. If your SAM.gov 

registration is expired, you will not be 

able to submit an application. It can take 

several weeks to renew it or resolve any 

issues with your registration, so do not 

wait. 

Check your Grants.gov registration. 

Registration and role assignments in 

Grants.gov are self-serve functions. One 

user for your organization will have the 

authority to approve role assignments, 

and these must be approved for active 

users in order to ensure someone in 

your organization has the necessary 

access to submit an application. 

The Federal Funding Accountability 

and Transparency Act of 2006, as 

amended (‘‘Transparency Act’’), 

requires all HHS recipients to report 

information on sub-awards. 

Accordingly, all IHS recipients must 

notify potential first-tier sub-recipients 

that no entity may receive a first-tier 

sub-award unless the entity has 

provided its UEI number to the prime 

recipient organization. This requirement 

ensures the use of a universal identifier 

to enhance the quality of information 

available to the public pursuant to the 

Transparency Act. 

Additional information on 

implementing the Transparency Act, 

including the specific requirements for 

SAM, are available on the DGM Grants 

Management, Policy Topics web page at 

https://www.ihs.gov/dgm/policytopics/. 

V. Application Review Information 

Possible points assigned to each 

section are noted in parentheses. The 

project narrative and budget narrative 

should include only the first year of 

activities; information for multi-year 

projects should be included as a 

separate document. See ‘‘Multi-year 

Project Requirements’’ at the end of this 

section for more information. The 

project narrative should be written in a 

manner that is clear to outside reviewers 

unfamiliar with prior related activities 

of the applicant. It should be well 


lotter on DSK11XQN23PROD with NOTICES1
68636 Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 

organized, succinct, and contain all 

information necessary for reviewers to 

fully understand the project. 

Attachments requested in the criteria do 

not count toward the page limit for the 

narratives. Points will be assigned to 

each evaluation criteria adding up to a 

total of 100 possible points. Points are 

assigned as follows: 

1. Evaluation Criteria 

A. Introduction and Need for Assistance 

(15 points) 

(i) Program Identifiers/Experience 

(Project Narrative Part A) 

(1) Was program identifier 

information adequately provided? 

(2) Did applicant provide sufficient 

information to establish their location 

and relationship to their local Indian 

Health Clinic? 

(ii) Needs Assessment (Project Narrative 

Part B) 

(1) Did the applicant adequately 

describe the key diabetes-related health 

issues identified by their community/ 

leadership? 

(2) Were numbers provided for 

applicant’s local user population and 

people with diagnosed diabetes? 

(3) Did the applicant appropriately 

identify Diabetes Audit items (or 

diabetes-related issues if Audit Reports 

were not provided) that need to be 

improved? 

(4) Did the applicant adequately 

describe how they will address the 

Diabetes Audit items or diabetes-related 

issues that need to be improved? 

(5) Did the applicant adequately 

describe challenges? 

B. Project Objective(s), Work Plan and 

Approach (30 points) 

(i) SDPI Diabetes Best Practice (Project 

Narrative Part D) 

(1) Did the applicant provide an 

adequate description of activities/ 

services to improve the RKM? 

(2) Are the activities/services 

proposed appropriate for the selected 

Best Practice and Target Group? 

(3) Do the planned activities/services 

appear to be reasonable given the 

constraints of timeframe, resources, and 

staff? 

(ii) If Applicable: Activities/Services 

Not Related to Selected Best Practice 

(Project Narrative Part E) 

(1) Do activities/services address 

diabetes-related issues identified in the 

needs assessment in Part B? 

(2) Are activities/services aimed at 

reducing risk factors for diabetes and/or 

related conditions? 

(3) Are activities/services adequately 

described? 

(4) Do the planned activities/services 

appear to be reasonable given the 

constraints of timeframe, resources, and 

staff? 

C. Program Evaluation (15 points) 

(i) SDPI Diabetes Best Practice (Project 

Narrative Part D) 

(1) Was a Best Practice selected? 

(2) Was the number of patients/ 

participants in the Target Group 

provided? 

(3) Was the Target Group adequately 

described? 

(4) Are the Target Group and number 

of patients/participants reasonable given 

the information the applicant provided 

in their needs assessment and program 

resources sections? 

(ii) If Applicable: Activities/Services 

Not Related to Selected Best Practice 

(Project Narrative Part E) 

(1) Was an appropriate target group 

identified for each activity/service? 

(2) Did the applicant specify how 

improvement and reduction in risk 

factors will be evaluated? 

D. Organizational Capabilities, Key 

Personnel, and Qualifications (30 

points) 

(i) Program Identifiers/Experience 

(Project Narrative Part A) 

(1) Does the applicant have 

experience with diabetes treatment and 

prevention services in AI/AN 

communities? 

(2) Is the experience provided recent? 

(within 5 years) 

(ii) Program Support (Project Narrative 

Part C) 

(1) Does the program propose to 

provide sufficient and appropriate staff 

to carry out planned activities? 

(2) Did the applicant identify an 

appropriate organization administrator 

or Tribal leader, other than the Program 

Coordinator, to support their SDPI 

program? 

(3) Did the applicant describe how 

this leader will be involved with the 

SDPI program? 

(4) Did the applicant provide 

appropriate and adequate information 

about key personnel in the Project 

Narrative? 

(5) Did the applicant provide 

appropriate and adequate information 

about partnerships and collaborations in 

the Project Narrative? 

E. Categorical Budget and Budget 

Justification (10 points) 

(i) Does the budget match the scope of 

work described in the Project Narrative? 

(ii) Was each line item adequately 

specified and justified? 

(iii) Do funding totals match between 

the SF–424A, budget line item, and 

justification? 

(iv) Is the budget reasonable and 

realistic? 

Multi-Year Project Requirements 

Applications must include a brief 

project narrative and budget (one 

additional page per year) addressing the 

developmental plans for each additional 

year of the project. This attachment will 

not count as part of the project narrative 

or the budget narrative. 

2. Review and Selection 

Each application will be prescreened 

for eligibility and completeness as 

outlined in this funding announcement. 

The Review Committee (RC) will review 

applications that meet the eligibility 

criteria. The RC will review the 

applications for merit based on the 

evaluation criteria. Incomplete 

applications and applications that are 

not responsive to the administrative 

thresholds (budget limit, period of 

performance limit) will not be referred 

to the RC and will not be funded. The 

DGM will notify the applicant of this 

determination. 

Applicants must address all program 

requirements and provide all required 

documentation. 

3. Notifications of Disposition 

All applicants will receive an 

Executive Summary Statement from the 

IHS DDTP within 30 days of the 

conclusion of the review outlining the 

strengths and weaknesses of their 

application. The summary statement 

will be sent to the Authorizing Official 

identified on the face page (SF–424) of 

the application. 

A. Award Notices for Funded 

Applications 

The NoA is the authorizing document 

for which funds are dispersed to the 

approved entities and reflects the 

amount of Federal funds awarded, the 

purpose of the award, the terms and 

conditions of the award, the effective 

date of the award, the budget period, 

and period of performance. Each entity 

approved for funding must have a user 

account in GrantSolutions in order to 

retrieve the NoA. Please see the Agency 

Contacts list in Section VII for the 

systems contact information. 

B. Approved but Unfunded 

Applications 

Approved applications not funded 

due to lack of available funds will be 

held for 1 year. If funding becomes 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 68637 

available during the course of the year, 

the application may be reconsidered. 

Note: Any correspondence other than the 

official NoA executed by an IHS grants 

management official announcing to the 

project director that an award has been made 

to their organization is not an authorization 

to implement their program on behalf of the 

IHS. 

VI. Award Administration Information 

1. Administrative Requirements 

Awards issued under this 

announcement are subject to, and are 

administered in accordance with, the 

following regulations and policies: 

A. The criteria as outlined in this 

program announcement. 

B. Administrative Regulations for 

Awards: 

• Uniform Administrative 

Requirements, Cost Principles, and 

Audit Requirements for HHS Awards 

currently in effect or implemented 

during the period of award, other 

Department regulations and policies in 

effect at the time of award, and 

applicable statutory provisions. At the 

time of publication, this includes 45 

CFR part 75, at https://www.govinfo.gov/ 

content/pkg/CFR-2022-title45-vol1/pdf/ 

CFR-2022-title45-vol1-part75.pdf. 

• If you receive an award, HHS may 

terminate it if any of the conditions in 

2 CFR 200.340(a)(1)–(4) are met. Please 

review all HHS regulatory provisions for 

Termination at 45 CFR 75.372, at the 

time of this publication located at 

https://www.govinfo.gov/content/pkg/ 

CFR-2022-title45-vol1/pdf/CFR-2022- 

title45-vol1-sec75-372.pdf. 

C. Grants Policy: 

• HHS Grants Policy Statement, 

Revised January 2007, at https://

www.hhs.gov/sites/default/files/grants/ 

grants/policies-regulations/

hhsgps107.pdf. 

D. Cost Principles: 

• Uniform Administrative 

Requirements for HHS Awards, ‘‘Cost 

Principles,’’ at 45 CFR part 75 subpart 

E, at the time of this publication located 

at https://www.govinfo.gov/content/pkg/ 

CFR-2022-title45-vol1/pdf/CFR-2022- 

title45-vol1-part75-subpartE.pdf. 

E. Audit Requirements: 

• Uniform Administrative 

Requirements for HHS Awards, ‘‘Audit 

Requirements,’’ at 45 CFR part 75 

subpart F, at the time of this publication 

located at https://www.govinfo.gov/ 

content/pkg/CFR-2022-title45-vol1/pdf/ 

CFR-2022-title45-vol1-part75- 

subpartF.pdf. 

F. As of August 13, 2020, 2 CFR part 

200 was updated to include a 

prohibition on certain 

telecommunications and video 

surveillance services or equipment. This 

prohibition is described in 2 CFR 

200.216. This will also be described in 

the terms and conditions of every IHS 

grant and cooperative agreement 

awarded on or after August 13, 2020. 

2. Indirect Costs 

This section applies to all recipients 

that request reimbursement of IDC in 

their application budget. In accordance 

with HHS Grants Policy Statement, Part 

II–27, the IHS requires applicants to 

obtain a current IDC rate agreement and 

submit it to the DGM prior to the DGM 

issuing an award. The rate agreement 

must be prepared in accordance with 

the applicable cost principles and 

guidance as provided by the cognizant 

agency or office. A current rate covers 

the applicable award activities under 

the current award’s budget period. If the 

current rate agreement is not on file 

with the DGM at the time of award, the 

IDC portion of the budget will be 

restricted. The restrictions remain in 

place until the current rate agreement is 

provided to the DGM. Per 2 CFR 

200.414(f) Indirect (F&A) costs, 

any non-Federal entity (NFE) [i.e., applicant] 

that does not have a current negotiated rate, 

. . . may elect to charge a de minimis rate 

of 10 percent of modified total direct costs 

which may be used indefinitely. As 

described in Section 200.403, costs must be 

consistently charged as either indirect or 

direct costs, but may not be double charged 

or inconsistently charged as both. If chosen, 

this methodology once elected must be used 

consistently for all Federal awards until such 

time as the NFE chooses to negotiate for a 

rate, which the NFE may apply to do at any 

time. 

Electing to charge a de minimis rate 

of 10 percent can be used by applicants 

that have received an approved 

negotiated indirect cost rate from HHS 

or another cognizant Federal agency. 

Applicants awaiting approval of their 

indirect cost proposal may request the 

10 percent de minimis rate. When the 

applicant chooses this method, costs 

included in the indirect cost pool must 

not be charged as direct costs to the 

award. Available funds are inclusive of 

direct and appropriate indirect costs. 

Approved indirect funds are awarded as 

part of the award amount, and no 

additional funds will be provided. 

Generally, IDC rates for IHS recipients 

are negotiated with the Division of Cost 

Allocation at https://rates.psc.gov/ or 

the Department of the Interior (Interior 

Business Center) at https://ibc.doi.gov/ 

ICS/tribal. For questions regarding the 

indirect cost policy, please write to 

DGM@ihs.gov. 

3. Reporting Requirements 

The recipient must submit required 

reports consistent with the applicable 

deadlines. Failure to submit required 

reports within the time allowed may 

result in suspension or termination of 

an active award, withholding of 

additional awards for the project, or 

other enforcement actions such as 

withholding of payments or converting 

to the reimbursement method of 

payment. Continued failure to submit 

required reports may result in the 

imposition of special award provisions 

and/or the non-funding or non-award of 

other eligible projects or activities. This 

requirement applies whether the 

delinquency is attributable to the failure 

of the recipient organization or the 

individual responsible for preparation 

of the reports. Per DGM policy, all 

reports must be submitted electronically 

by attaching them as a ‘‘Grant Note’’ in 

GrantSolutions. Personnel responsible 

for submitting reports will be required 

to obtain a login and password for 

GrantSolutions. Please use the form 

under the Recipient User section of 

https://www.grantsolutions.gov/home/ 

getting-started-request-a-user-account/. 

Download the Recipient User Account 

Request Form, fill it out completely, and 

submit it as described on the web page 

and in the form. 

The reporting requirements for this 

program are noted below. 

A. Progress Reports 

Program progress reports are required 

annually. The progress reports are due 

within 30 days after the reporting period 

ends (specific dates will be listed in the 

NoA Terms and Conditions). These 

reports must include a brief comparison 

of actual accomplishments to the goals 

established for the period, a summary of 

progress to date or, if applicable, 

provide sound justification for the lack 

of progress, and other pertinent 

information as required. Recipient must 

submit a final report within 120 days of 

the period of performance end date. 

Instructions, template(s), and other 

information will be posted on the SDPI 

website at https://www.ihs.gov/sdpi/ 

sdpi-community-directed/applicationreports/. 

B. Financial Reports 

Federal Financial Reports are due 90 

days after the end of each budget period, 

and a final report is due 120 days after 

the end of the period of performance. 

Recipients are responsible and 

accountable for reporting accurate 

information on all required reports: the 

Progress Reports and the Federal 

Financial Report. 


lotter on DSK11XQN23PROD with NOTICES1
68638 Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 

Failure to submit timely reports may 

result in adverse award actions blocking 

access to funds. 

C. Data Collection and Reporting 

SOS RKM Data Requirements: Data 

for the selected Best Practice RKM will 

be submitted using the SOS. Recipients 

will submit results for their RKM for 

their selected Best Practice into this 

system at the start (baseline) and end 

(final) of the budget period, with the 

option to submit more frequently. The 

system will generate SOS RKM data 

reports to meet the SDPI outcomes 

reporting requirements. These results 

will be stored in the system and will be 

accessible to program staff, as needed. 

Recipients will need to appoint at least 

one person in their program to get 

access to and submit data into the SOS. 

i. Baseline data: Data is to be 

submitted into the SOS by the last 

business day of February each year (e.g., 

2024 baseline data will be by Thursday, 

February 29, 2024). A report from the 

SOS showing baseline data submission 

will be due with continuation 

applications. 

ii. Final data: Data for the prior 

budget period is to be submitted into the 

SOS by the last business day of January, 

each year (e.g., 2024 final data will be 

due by Friday, January 31, 2025). A 

report from the SOS showing baseline 

and final data submission will be due 

with the Annual Progress Report. 

Refer to the SDPI website (https://

www.ihs.gov/sdpi/) for the latest 

information on report templates, due 

dates, webinars and submission 

instructions. 

Diabetes Care and Outcomes Audit: 

SDPI recipients are required to 

participate in the Annual Diabetes 

Audit (https://www.ihs.gov/diabetes/ 

audit/). Recipients will submit data, 

review results, and provide a copy of 

their Annual Diabetes Audit Report 

with their annual SDPI applications. 

Diabetes Annual Audit data are to be 

submitted into the WebAudit each year 

around mid-March, (e.g., 2024 Audit 

data collecting annual data will be due 

approximately March 15, 2024). Nonclinical or community-based recipients, 

that are not able to directly participate 

in the Diabetes Audit, will need to 

obtain a copy of the Annual Diabetes 

Audit Report from their local facility or 

Area Diabetes Consultant (https://

www.ihs.gov/diabetes/about-us/areadiabetes-consultants-adc/). 

D. Federal Sub-award Reporting System 

(FSRS) 

This award may be subject to the 

Transparency Act sub-award and 

executive compensation reporting 

requirements of 2 CFR part 170. 

The Transparency Act requires the 

OMB to establish a single searchable 

database, accessible to the public, with 

information on financial assistance 

awards made by Federal agencies. The 

Transparency Act also includes a 

requirement for recipients of Federal 

grants to report information about firsttier sub-awards and executive 

compensation under Federal assistance 

awards. 

The IHS has implemented a Term of 

Award into all IHS Standard Terms and 

Conditions, NoAs, and funding 

announcements regarding the FSRS 

reporting requirement. This IHS Term of 

Award is applicable to all IHS grant and 

cooperative agreements issued on or 

after October 1, 2010, with a $25,000 

sub-award obligation threshold met for 

any specific reporting period. 

For the full IHS award term 

implementing this requirement and 

additional award applicability 

information, visit the DGM Grants 

Management website at https://

www.ihs.gov/dgm/policytopics/. 

E. Non-Discrimination Legal 

Requirements for Recipients of Federal 

Financial Assistance (FFA) 

If you receive an award, you must 

follow all applicable nondiscrimination 

laws. You agree to this when you 

register in SAM.gov. You must also 

submit an Assurance of Compliance 

(HHS–690). To learn more, see https:// 

www.hhs.gov/civil-rights/for-providers/ 

laws-regulations-guidance/laws/ 

index.html. Pursuant to 45 CFR 80.3(d), 

an individual shall not be deemed 

subjected to discrimination by reason of 

their exclusion from benefits limited by 

Federal law to individuals eligible for 

benefits and services from the IHS. 

F. Federal Awardee Performance and 

Integrity Information System (FAPIIS) 

The IHS is required to review and 

consider any information about the 

applicant that is in the FAPIIS at 

https://www.fapiis.gov/fapiis/#/home 

before making any award in excess of 

the simplified acquisition threshold 

(currently $250,000) over the period of 

performance. An applicant may review 

and comment on any information about 

itself that a Federal awarding agency 

previously entered. The IHS will 

consider any comments by the 

applicant, in addition to other 

information in FAPIIS, in making a 

judgment about the applicant’s integrity, 

business ethics, and record of 

performance under Federal awards 

when completing the review of risk 

posed by applicants, as described in 45 

CFR 75.205. 

As required by 45 CFR part 75 

Appendix XII of the Uniform Guidance, 

NFEs are required to disclose in FAPIIS 

any information about criminal, civil, 

and administrative proceedings, and/or 

affirm that there is no new information 

to provide. This applies to NFEs that 

receive Federal awards (currently active 

grants, cooperative agreements, and 

procurement contracts) greater than $10 

million for any period of time during 

the period of performance of an award/ 

project. 

Mandatory Disclosure Requirements 

As required by 2 CFR part 200 of the 

Uniform Guidance, and the HHS 

implementing regulations at 45 CFR part 

75, the IHS must require an NFE or an 

applicant for a Federal award to 

disclose, in a timely manner, in writing 

to the IHS or pass-through entity all 

violations of Federal criminal law 

involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 

All applicants and recipients must 

disclose in writing, in a timely manner, 

to the IHS and to the HHS Office of 

Inspector General all information 

related to violations of Federal criminal 

law involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 45 CFR 75.113. 

Disclosures must be sent in writing to: 

U.S. Department of Health and Human 

Services Indian Health Service, 

Division of Grants Management, 

ATTN: Marsha Brookins, Director, 

5600 Fishers Lane, Mail Stop: 09E70, 

Rockville, MD 20857, (Include 

‘‘Mandatory Grant Disclosures’’ in 

subject line), Office: (301) 443–4750, 

Fax: (301) 594–0899, Email: DGM@

ihs.gov 

AND 

U.S. Department of Health and Human 

Services, Office of Inspector General, 

ATTN: Mandatory Grant Disclosures, 

Intake Coordinator, 330 Independence 

Avenue SW, Cohen Building, Room 

5527, Washington, DC 20201, URL: 

https://oig.hhs.gov/fraud/reportfraud/, (Include ‘‘Mandatory Grant 

Disclosures’’ in subject line), Fax: 

(202) 205–0604 (Include ‘‘Mandatory 

Grant Disclosures’’ in subject line) or 

Email: 

MandatoryGranteeDisclosures@

oig.hhs.gov 

Failure to make required disclosures 

can result in any of the remedies 

described in 45 CFR 75.371 Remedies 

for noncompliance, including 

suspension or debarment (see 2 CFR 

part 180 and 2 CFR part 376). 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 68639 

VII. Agency Contacts 

1. Questions on the programmatic 

issues may be directed to: 

Applicant’s Area Diabetes Consultant: 

https://www.ihs.gov/diabetes/aboutus/area-diabetes-consultants-adc/, 

IHS Division of Diabetes Treatment 

and Prevention, 5600 Fishers Lane, 

Mailstop: 08N34A, Rockville, MD 

20857, Phone: (844) 447–3387, Fax: 

(301) 594–6213, Email: 

diabetesprogram@ihs.gov and sdpi@

ihs.gov, Division of Diabetes website: 

https://www.ihs.gov/diabetes/ and 

https://www.ihs.gov/sdpi/ 

2. Questions on awards management 

and fiscal matters may be directed to: 

Indian Health Service, Division of 

Grants Management, 5600 Fishers 

Lane, Mail Stop: 09E70, Rockville, 

MD 20857, Email: DGM@ihs.gov. 

3. For technical assistance with 

Grants.gov, please contact the 

Grants.gov help desk at (800) 518–4726, 

or by email at support@grants.gov. 

4. For technical assistance with 

GrantSolutions, please contact the 

GrantSolutions help desk at (866) 577– 

0771, or by email at help@

grantsolutions.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all grant, cooperative 

agreement, and contract recipients to 

provide a smoke-free workplace and 

promote the non-use of all tobacco 

products. In addition, Public Law 103– 

227, the Pro-Children Act of 1994, 

prohibits smoking in certain facilities 

(or in some cases, any portion of the 

facility) in which regular or routine 

education, library, day care, health care, 

or early childhood development 

services are provided to children. This 

is consistent with the HHS mission to 

protect and advance the physical and 

mental health of the American people. 

Roselyn Tso, 

Director, Indian Health Service. 

[FR Doc. 2023–22057 Filed 10–3–23; 8:45 am] 

BILLING CODE 4166–14–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Developing Digital Therapeutics for 

Substance Use Disorders. 

Date: November 14, 2023. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Jenny Raye Browning, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Research, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue, MSC 

6021, Bethesda, MD 20892, (301) 443–4577, 

jenny.browning@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 

Dated: September 29, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–22045 Filed 10–3–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Board of Scientific 

Counselors, National Cancer Institute, 

November 13, 2023, 10 a.m. to 

November 14, 2023, 1:45 p.m., National 

Institute of Health, Building 31, C Wing, 

6th Floor, Conference Room C, 9000 

Rockville Pike, Bethesda, MD 20892, 

which was published in the Federal 

Register on September 28, 2023, FR Doc 

2023–21147, 88 FR 66861. 

This meeting notice is being amended 

to change the meeting type from 

partially closed to closed. Due to 

scheduling difficulties, there will no 

longer be an open session of the 

meeting. The meeting is closed to the 

public. 

Dated: September 28, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21974 Filed 10–3–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Human 

Genome Research Institute Special Emphasis 

Panel; High Quality Reference Genomes 

(HQRG). 

Date: November 29, 2023. 

Time: 3:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Rudy O. Pozzatti, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, MSC 6908, Bethesda, MD 

20892, (301) 402–8739, pozzattr@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: September 28, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21889 Filed 10–3–23; 8:45 am] 

BILLING CODE 4140–01–P 


lotter on DSK11XQN23PROD with NOTICES1